SCHEMBL22014351

SCHEMBL22014351

CNC(=O)Cc1c(C(C)C)cc2c(c1C(C)C)COC2(C)C

nearest known ligand 0.31

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
CYP26A1 O43174 1/20 0.31
CYP26B1 Q9NR63 1/20 0.31
RXRA P19793 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22014397 0.86 CYP26A1 (0.37) CYP26A1CYP26B1RXRA
SCHEMBL21962058 0.85
SCHEMBL22014398 0.81
SCHEMBL21962217 0.74
SCHEMBL21962328 0.74
SCHEMBL22014721 0.64
SCHEMBL21962221 0.62 KDM4E (0.32)
SCHEMBL23319827 0.61
SCHEMBL22015607 0.61 HSP90AA1 (0.33)
SCHEMBL25067272 0.60 KCNJ1 (0.33)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020102574-A1 THE COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH NLRP ACTIVITY NOVARTIS INFLAMMASOME RESEARCH, INC. (US) 2020-05-22 WO disclosed